Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ocular Therapeutix announces first patient dosed in phase 1 clinical trial of OTX-CSI to treat dry e

pharmaceutical-business-reviewMay 15, 2020

Tag: Ocular Therapeutix , OTX-CSI , Dry Eye Disease

PharmaSources Customer Service